Patents by Inventor Eun-Jin Lim

Eun-Jin Lim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR STABILIZING EFFECTIVE INGREDIENT BY USING MINERAL MATERIAL
    Publication number: 20240091730
    Abstract: The present invention relates to the stabilization of an effective ingredient by using a mineral material. In the present invention, the effective ingredient can be stably supported using the mineral material, and a microcapsule obtained by the manufacturing method according to the present invention, when discharged to nature, causes no environmental problems due to encapsulation ingredients thereof being the same as soil ingredients, and thus can avoid micro-plastic issues.
    Type: Application
    Filed: December 28, 2021
    Publication date: March 21, 2024
    Applicants: LG HOUSEHOLD & HEALTH CARE LTD., IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY)
    Inventors: Jun Seok YEOM, Eun Chul CHO, Ji Won LIM, Hyo Jin BONG, Seon A JEONG, No Jin PARK, Woo Sun SHIM
  • COMPOSITION FOR CULTURING NK CELLS AND METHOD FOR CULTURING NK CELLS USING SAME
    Publication number: 20230365932
    Abstract: Provided are a composition for culturing NK cells, and a method of culturing NK cells using the same. According to an aspect, in culturing NK cells from peripheral blood mononuclear cells, when NK cells are cultured in a medium including the composition for culturing NK cells, the composition including IL-15, IL-18, and IL-27, the NK cells may proliferate in large quantities and activation of NK cells may be promoted. Therefore, when the NK cells are used, cancer cell apoptosis or cancer cell-killing ability may be promoted. Accordingly, the NK cells may be used as an effective adoptive immune cell therapy product in cancer prevention or treatment.
    Type: Application
    Filed: July 17, 2023
    Publication date: November 16, 2023
    Applicant: SUNGKWANG MEDICAL FOUNDATION
    Inventors: Hee Jung AN, Yeon Ho CHOI, Eun Jin LIM, Yong Wha MOON, Se Wha KIM
  • Composition for culturing NK cells and method for culturing NK cells using same
    Patent number: 11746327
    Abstract: Provided are a composition for culturing NK cells, and a method of culturing NK cells using the same. According to an aspect, in culturing NK cells from peripheral blood mononuclear cells, when NK cells are cultured in a medium including the composition for culturing NK cells, the composition including IL-15, IL-18, and IL-27, the NK cells may proliferate in large quantities and activation of NK cells may be promoted. Therefore, when the NK cells are used, cancer cell apoptosis or cancer cell-killing ability may be promoted. Accordingly, the NK cells may be used as an effective adoptive immune cell therapy product in cancer prevention or treatment.
    Type: Grant
    Filed: November 20, 2018
    Date of Patent: September 5, 2023
    Assignee: SUNGKWANG MEDICAL FOUNDATION
    Inventors: Hee Jung An, Yeon Ho Choi, Eun Jin Lim, Yong Wha Moon, Se Wha Kim
  • COMPOSITION FOR CULTURING NK CELLS AND METHOD FOR CULTURING NK CELLS USING SAME
    Publication number: 20210095249
    Abstract: Provided are a composition for culturing NK cells, and a method of culturing NK cells using the same. According to an aspect, in culturing NK cells from peripheral blood mononuclear cells, when NK cells are cultured in a medium including the composition for culturing NK cells, the composition including IL-15, IL-18, and IL-27, the NK cells may proliferate in large quantities and activation of NK cells may be promoted. Therefore, when the NK cells are used, cancer cell apoptosis or cancer cell-killing ability may be promoted. Accordingly, the NK cells may be used as an effective adoptive immune cell therapy product in cancer prevention or treatment.
    Type: Application
    Filed: November 20, 2018
    Publication date: April 1, 2021
    Applicant: SUNGKWANG MEDICAL FOUNDATION
    Inventors: Hee Jung AN, Yeon Ho CHOI, Eun Jin LIM, Yong Wha MOON, Se Wha KIM
  • Method of treating eye disease using glycosylated VEGF decoy receptor fusion protein
    Patent number: 9856462
    Abstract: The present application describes an isolated nucleic acid molecule encoding a polypeptide capable of synchronously binding VEGF polypeptide and placenta growth factor (PIGF) polypeptide comprising a nucleotide sequence encoding a VEGFR1 component.
    Type: Grant
    Filed: June 15, 2015
    Date of Patent: January 2, 2018
    Assignees: Korean Advanced Insititute of Science and Technology (KAIST), Seoul National University Bundang Hospital
    Inventors: Ho Min Kim, Hye Kyoung Hong, Se Joon Woo, Eun-Jin Lim, Kyu Hyung Park
  • METHOD OF TREATING EYE DISEASE USING GLYCOSYLATED VEGF DECOY RECEPTOR FUSION PROTEIN
    Publication number: 20160024483
    Abstract: The present application describes an isolated nucleic acid molecule encoding a polypeptide capable of synchronously binding VEGF polypeptide and placenta growth factor (PIGF) polypeptide comprising a nucleotide sequence encoding a VEGFR1 component.
    Type: Application
    Filed: June 15, 2015
    Publication date: January 28, 2016
    Inventors: Ho Min KIM, Hye Kyoung Hong, Se Joon Woo, Eun-Jin Lim, Kyu Hyung Park